Latest Breaking News On - Treating idiopathic pulmonary fibrosis - Page 1 : comparemela.com

Algernon Pharmaceuticals Inc Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Inc. announced that it has received a notice of allowance from the Japanese Patent Office for patent application No. 2021-547495 entitled: Compositions and Methods for.

Algernon pharmaceuticals incJapanese patent officeAlgernon pharmaceuticalsTreating idiopathic pulmonary fibrosis

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomChristopherj moreauJapanese patent officeAlgernon pharmaceuticals incAlgernon pharmaceuticalsCompany or algernonTreating idiopathic pulmonary fibrosisAlgernon neuroscience

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of Ifenprodil for Idiopathic Pulmonary Fibrosis and Chronic Cough | Comunicados | Edición USA

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of Ifenprodil for Idiopathic Pulmonary Fibrosis and Chronic Cough | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaChristopherj moreauMartin kolbJacky smithAirway fibrosisMcmaster universityInternational colloquium on lungHonorary consultant at manchester universityUniversity of manchesterAlgernon pharmaceuticals hits coAlgernon pharmaceuticals incCompany or algernonCanadian intellectual property officeAlgernon pharmaceuticals hits co primary endpointIdiopathic pulmonary fibrosis

Algernon Pharmaceuticals Inc granted Ifenprodil patent for idiopathic pulmonary fibrosis in Canada

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF), the drug repurposing group, said the Canadian patent office has approved its application for a claim.

Algernon pharmaceuticals incAlgernon pharmaceuticalsTreating idiopathic pulmonary fibrosis

NA Proactive news snapshot: Fobi AI Inc, Heritage Cannabis Holdings Corp, Thesis Gold Inc, Algernon Pharmaceuticals Inc, World Copper Ltd

NA Proactive news snapshot: Fobi AI Inc, Heritage Cannabis Holdings Corp, Thesis Gold Inc, Algernon Pharmaceuticals Inc, World Copper Ltd
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Moss lakeUnited statesThunder bayUnited kingdomBritish columbiaLac des ilesMichael auerbachJeffry allenLeland henschFobi qplesDavid schwedeGlassman chreinEwan websterBrett richardsJason paltrowitzKen hershman